Plant food anthocyanins inhibit platelet granule secretion in hypercholesterolaemia: Involving the signalling pathway of PI3K–Akt

Summary

Controlling platelet granule secretion has been considered an effective strategy to dampen thrombosis and prevent atherosclerosis. Anthocyanins are natural plant pigments and possess a wide range of biological activities, including cardiovascular protective activity. In the present study we explored the effects and the potential mechanisms of anthocyanins on platelet granule secretion in hypercholesterolemia. In a randomised, double-blind clinical trial, 150 hypercholesterolaemic individuals were treated with purified anthocyanins (320 mg/day) or placebo for 24 weeks. Anthocyanins consumption significantly reduced plasma levels of β-thromboglobulin (β-TG), soluble P-selectin, and of Regulated on Activation Normal T cell Expressed and Secreted (RANTES) as compared with the placebo. A minor reduction in platelet factor 4 (PF4) and transforming growth factor β1 (TGF-β1) levels were also observed. In in vitro experiments, we observed that purified anthocyanin mixture, as well as its two main anthocyanin components, delphinidin-3-glucoside (Dp-3-g) and cyanidin-3-glucoside (Cy-3g) directly inhibited platelet á-granule, dense granule, and lysosome secretion evaluated by P-selectin, RANTES, β-TG, PF4, TGF-β1, serotonin, ATP, and CD63 release. Further, anthocyanins inhibited platelet PI3K/Akt activation and consequently attenuated eNOS phosphorylation and cGMP production, thus interrupting MAPK activation. LY294002, a PI3K inhibitor, did not cause additional inhibitory efficacy, indicating that anthocyanin-induced effects may be involved in inhibition of the PI3K/Akt signalling pathway. These results provide evidence that by inhibiting platelet granule secretion, anthocyanins may be a potent cardioprotective agent.

Keywords

Hypercholesterolaemia - platelet granule - anthocyanins - PI3K

• References

• 1 Ruggeri ZM. Platelets in atherothrombosis. Nat Med 2002; 8: 1227-1234.
• 2 Ni H, Freedman J. Platelets in haemostasis and thrombosis: role of integrins and their ligands. Transfus Apher Sci 2003; 28: 257-264.
• 3 Li C, Li J, Li Y. et al. Crosstalk between Platelets and the Immune System: Old Systems with New Discoveries. Adv Hematol 2012; 2012: 384685.
• 4 Murphy AJ, Bijl N, Yvan-Charvet L. et al. Cholesterol efflux in megakaryocyte progenitors suppresses platelet production and thrombocytosis. Nat Med 2013; 19: 586-594.
• 5 Blair P, Flaumenhaft R. Platelet alpha-granules: basic biology and clinical correlates. Blood Rev 2009; 23: 177-189.
• 6 McNicol A, Israels SJ. Platelet dense granules: structure, function and implications for haemostasis. Thromb Res 1999; 95: 1-18.
• 7 Li J, Callum JL, Lin Y. et al. Severe platelet desialylation in a patient with glyco-protein Ib/IX antibody-mediated immune thrombocytopenia and fatal pulmonary haemorrhage. Haematologica 2014; 99: e61-63.
• 8 Rendu F, Brohard-Bohn B. The platelet release reaction: granules’ constituents, secretion and functions. Platelets 2001; 12: 261-273.
• 9 Shirakawa R, Yoshioka A, Horiuchi H. et al. Small GTPase Rab4 regulates Ca²⁺-induced alpha-granule secretion in platelets. J Biol Chem 2000; 275: 33844-33849.
• 10 Cipollone F, Mezzetti A, Porreca E. et al. Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolaemia: effects of statin therapy. Circulation 2002; 106: 399-402.
• 11 Prisco D, Rogasi PG, Paniccia R. et al. Altered lipid composition and thromboxane A2 formation in platelets from patients affected by IIa hyperlipoproteinemia. Thromb Res 1988; 50: 593-604.
• 12 King SM, McNamee RA, Houng AK. et al. Platelet dense-granule secretion plays a critical role in thrombosis and subsequent vascular remodeling in athero-sclerotic mice. Circulation 2009; 120: 785-791.
• 13 Paigen B, Holmes PA, Novak EK. et al. Analysis of atherosclerosis susceptibility in mice with genetic defects in platelet function. Arteriosclerosis 1990; 10: 648-652.
• 14 Kennedy SG, Wagner AJ, Conzen SD. et al. The PI3-kinase/Akt signalling pathway delivers an anti-apoptotic signal. Genes Dev 1997; 11: 701-713.
• 15 Morello F, Perino A, Hirsch E. Phosphoinositide 3-kinase signalling in the vascular system. Cardiovasc Res 2009; 82: 261-271.
• 16 Li Z, Delaney MK, O’Brien KA. et al. Signalling during platelet adhesion and activation. Arterioscler Thromb Vasc Biol 2010; 30: 2341-2349.
• 17 Wallace TC. Anthocyanins in cardiovascular disease. Adv Nutr 2011; 2: 1-7.
• 18 Karlsen A, Retterstol L, Laake P. et al. Anthocyanins inhibit nuclear factor-kappaB activation in monocytes and reduce plasma concentrations of pro-inflammatory mediators in healthy adults. J Nutr 2007; 137: 1951-1954.
• 19 Yang Y, Shi Z, Reheman A. et al. Plant food delphinidin-3-glucoside significantly inhibits platelet activation and thrombosis: novel protective roles against cardiovascular diseases. PLoS One 2012; 7: e37323.
• 20 Rechner AR, Kroner C. Anthocyanins and colonic metabolites of dietary polyphenols inhibit platelet function. Thromb Res 2005; 116: 327-334.
• 21 Yang Y, Andrews MC, Hu Y. et al. Anthocyanin extract from black rice significantly ameliorates platelet hyperactivity and hypertriglyceridemia in dyslipidaemc rats induced by high fat diets. J Agric Food Chem 2011; 59: 6759-6764.
• 22 Zhu Y, Xia M, Yang Y. et al. Purified anthocyanin supplementation improves endothelial function via NO-cGMP activation in hypercholesterolaemic individuals. Clin Chem 2011; 57: 1524-1533.
• 23 Zhu Y, Ling W, Guo H. et al. Anti-inflammatory effect of purified dietary anthocyanin in adults with hypercholesterolaemia: a randomized controlled trial. Nutr Metab Cardiovasc Dis 2013; 23: 843-849.
• 24 Yang H, Reheman A, Chen P. et al. Fibrinogen and von Willebrand factor-independent platelet aggregation in vitro and in vivo. J Thromb Haemost 2006; 4: 2230-2237.
• 25 Li Z, Zhang G, Le Breton GC. et al. Two waves of platelet secretion induced by thromboxane A2 receptor and a critical role for phosphoinositide 3-kinases. J Biol Chem 2003; 278: 30725-30731.
• 26 Kroner C, Eybrechts K, Akkerman JW. Dual regulation of platelet protein kinase B. J Biol Chem 2000; 275: 27790-27798.
• 27 Stojanovic A, Marjanovic JA, Brovkovych VM. et al. A phosphoinositide 3-kinase-AKT-nitric oxide-cGMP signalling pathway in stimulating platelet secretion and aggregation. J Biol Chem 2006; 281: 16333-16339.
• 28 Li Z, Xi X, Du X. A mitogen-activated protein kinase-dependent signalling pathway in the activation of platelet integrin alpha IIbbeta3. J Biol Chem 2001; 276: 42226-42232.
• 29 Flevaris P, Li Z, Zhang G. et al. Two distinct roles of mitogen-activated protein kinases in platelets and a novel Rac1-MAPK-dependent integrin outside-in retractile signalling pathway. Blood 2009; 113: 893-901.
• 30 Kramer RM, Roberts EF, Strifler BA. et al. Thrombin induces activation of p38 MAP kinase in human platelets. J Biol Chem 1995; 270: 27395-27398.
• 31 Bugaud F, Nadal-Wollbold F, Levy-Toledano S. et al. Regulation of c-jun-NH2 terminal kinase and extracellular-signal regulated kinase in human platelets. Blood 1999; 94: 3800-3805.
• 32 Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Invest 2005; 115: 3378-3384.
• 33 King SM, Reed GL. Development of platelet secretory granules. Semin Cell Dev Biol 2002; 13: 293-302.
• 34 Yang H, Lang S, Zhai Z. et al. Fibrinogen is required for maintenance of platelet intracellular and cell-surface P-selectin expression. Blood 2009; 112: 425-436.
• 35 Kaplan KL, Owen J. Plasma levels of beta-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood 1981; 57: 199-202.
• 36 Lane DA, Ireland H, Wolff S. et al. Detection of enhanced in vivo platelet alpha-granule release in different patient groups--comparison of beta-thromboglobulin, platelet factor 4 and thrombospondin assays. Thromb Haemost 1984; 52: 183-187.
• 37 Assoian RK, Komoriya A, Meyers CA. et al. Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J Biol Chem 1983; 258: 7155-7160.
• 38 Ferroni P, Martini F, Riondino S. et al. Soluble P-selectin as a marker of in vivo platelet activation. Clin Chim Acta 2009; 399: 88-91.
• 39 Podrez EA, Byzova TV, Febbraio M. et al. Platelet CD36 links hyperlipidaema, oxidant stress and a prothrombotic phenotype. Nat Med 2007; 13: 1086-1095.
• 40 Friend M, Vucenik I, Miller M. Research pointers: Platelet responsiveness to aspirin in patients with hyperlipidaemia. BMJ 2003; 326: 82-83.
• 41 Hohlfeld T, Scharnowski F, Braun M. et al. Antiplatelet effects of ticlopidine are reduced in experimental hypercholesterolaemia. Thromb Haemost 1994; 71: 112-118.
• 42 McGhie TK, Walton MC. The bioavailability and absorption of anthocyanins: towards a better understanding. Mol Nutr Food Res 2007; 51: 702-713.
• 43 Kay CD. Aspects of anthocyanin absorption, metabolism and pharmacokinetics in humans. Nutr Res Rev 2006; 19: 137-146.
• 44 Garcia-Alonso M, Minihane AM, Rimbach G. et al. Red wine anthocyanins are rapidly absorbed in humans and affect monocyte chaemoattractant protein 1 levels and antioxidant capacity of plasma. J Nutr Biochem 2009; 20: 521-529.
• 45 Kim K, Bae ON, Lim KM. et al. Novel antiplatelet activity of protocatechuic acid through the inhibition of high shear stress-induced platelet aggregation. J Pharmacol Exp Ther 2012; 343: 704-711.
• 46 Voss B, McLaughlin JN, Holinstat M. et al. PAR1, but not PAR4, activates human platelets through a Gi/o/phosphoinositide-3 kinase signalling axis. Mol Pharmacol 2007; 71: 1399-1406.
• 47 Radomski MW, Palmer RM, Moncada S. The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem Biophys Res Commun 1987; 148: 1482-1489.
• 48 Radomski MW, Palmer RM, Moncada S. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci USA 1990; 87: 5193-5197.
• 49 Marjanovic JA, Li Z, Stojanovic A. et al. Stimulatory roles of nitric-oxide synthase 3 and guanylyl cyclase in platelet activation. J Biol Chem 2005; 280: 37430-37438.